SAN FRANCISCO, CA, September 06, 2013 /24-7PressRelease/ -- Larvol Sigma is the first free clinical trial and pipeline intelligence platform. In addition to enabling faster, easier access to ClinicalTrials.gov and EudraCT, the new platform also provides advanced analytics tailored to meet the specific needs of the pharmaceutical and biotech industries. With a database containing over 5,000 drugs as well as more than 150,000 individual drug trials across all major indications, Larvol Sigma is a comprehensive free resource for investigators, researchers and industry professionals. To preview Larvol Sigma, please visit http://www.larvolsigma.com.---
"Combined with our intelligence and social media tracking services, Larvol Sigma is an important part of our mission to redefine the way the pharmaceutical industry understands the market," commented company President, Bruno Larvol. "We worked closely with major pharmaceutical companies to develop a user-friendly pipeline platform which focuses on specific diseases, companies and mechanisms of action, and we have been deeply pleased with the initial response."
For more information regarding how The Larvol Group can assist your organization, please visit our booth at the conference. If you would like to schedule a meeting with Bruno Larvol or Vice-president Laura Farmer during the event, please contact Sean Thompson at email@example.com or (281) 630-3579.
About The Larvol Group, LLC: Founded in 2004, The Larvol Group (www.larvol.com) is a San Francisco-based competitive intelligence company which provides innovative business intelligence services for the pharmaceutical industry. Their customized Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, cardiovascular, metabolic diseases, CNS, immunology, women's health and pain management. Their diverse portfolio of clients includes top pharmaceutical companies and small to midsized biotech firms.
Press release service and press release distribution provided by http://www.24-7pressrelease.com
# # #